Kochupurackal P. Mohanakumar

Affiliations: 
Cell Biology and Physiology indian Institute of Chemical Biology 
Google:
"Kochupurackal Mohanakumar"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Raju A, Jaisankar P, Borah A, et al. (2018) 1-Methyl-4-Phenylpyridinium-Induced Death of Differentiated SH-SY5Y Neurons Is Potentiated by Cholesterol. Annals of Neurosciences. 24: 243-251
Nthenge-Ngumbau DN, Mohanakumar KP. (2017) Can Cyclic Nucleotide Phosphodiesterase Inhibitors Be Drugs for Parkinson's Disease? Molecular Neurobiology
Dutta D, Ali N, Banerjee E, et al. (2017) Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease. Molecular Neurobiology
Singh A, Verma P, Balaji G, et al. (2016) Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice. Neurochemistry International
Dutta D, Mohanakumar KP. (2015) Tea and Parkinson's disease: Constituents of tea synergize with antiparkinsonian drugs to provide better therapeutic benefits. Neurochemistry International. 89: 181-190
Chakraborty J, Rajamma U, Jana N, et al. (2015) Quercetin improves the activity of the ubiquitin-proteasomal system in 150Q mutated huntingtin-expressing cells but exerts detrimental effects on neuronal survivability. Journal of Neuroscience Research. 93: 1581-91
Jaiswal P, Mohanakumar KP, Rajamma U. (2015) Serotonin mediated immunoregulation and neural functions: Complicity in the aetiology of autism spectrum disorders. Neuroscience and Biobehavioral Reviews. 55: 413-31
Tripathy D, Chakraborty J, Mohanakumar KP. (2015) Antagonistic pleiotropic effects of nitric oxide in the pathophysiology of Parkinson's disease. Free Radical Research. 49: 1129-39
Naskar A, Prabhakar V, Singh R, et al. (2015) Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice. Journal of Pineal Research. 58: 262-74
Haobam R, Tripathy D, Kaidery NA, et al. (2015) Embryonic stem cells derived neuron transplantation recovery in models of parkinsonism in relation to severity of the disorder in rats. Rejuvenation Research. 18: 173-84
See more...